Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis

**Background:** Targeted therapy for cancer is becoming more frequent as the understanding of the molecular pathogenesis increases. Molecular testing must be done to use targeted therapy. Unfortunately, the testing turnaround time can delay the initiation of targeted therapy. **Objective:** To inve...

Full description

Saved in:
Bibliographic Details
Main Authors: Ubong Silas, Maximilian Blüher, Antonia Bosworth Smith, Rhodri Saunders
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2023-06-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.77686
Tags: Add Tag
No Tags, Be the first to tag this record!